Brughera Marco Maria
Director
Sale 10b5-1
- Shares
- 15,545
- Price
- $10.29
- Value
- $159,958
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•90 filings
FENC
FENNEC PHARMACEUTICALS INC.
Net sales of $523K over the last 3 months
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$523,018
0 buyers · 3 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$10,385,091
8 distinct insiders
Highlighted alerts
8
8 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get FENC insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
FENC overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
16
Voluntary view
P/S trades after deterministic checks
96
Administrative noise
Stored, never alerted
32
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 75,000
- Price
- $11.78
- Footnotes
- 2
Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2026, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). A portion of the sales proceeds from this transaction will be used by the reporting person to pay tax obligations of the reporting person. Shares acquired through the exercise of an option contract with exercise price of $5.10 and an expiration date of June 27, 2027.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Raykov Rosty
Former Director
Sale 10b5-1
- Shares
- 10,000
- Price
- $12.11
- Value
- $121,100
Sayad Pierre Sargis
Chief Medical Officer
SaleAlert
- Shares
- 12,000
- Price
- $12.18
- Value
- $146,160
Raykov Rosty
Former Director
Sale 10b5-1
- Shares
- 10,000
- Price
- $9.58
- Value
- $95,800
Southpoint Capital Advisors LP
10% owner
SaleAlert
- Shares
- 1,000,000
- Price
- $7.50
- Value
- $7,500,000
Raykov Rosty
Director
Sale 10b5-1
- Shares
- 10,000
- Price
- $7.54
- Value
- $75,400
Southpoint Capital Advisors LP
10% owner
SaleAlert
- Shares
- 19,341
- Price
- $8.79
- Value
- $170,048
Southpoint Capital Advisors LP
10% owner
SaleAlert
- Shares
- 85,918
- Price
- $8.79
- Value
- $755,193
Southpoint Capital Advisors LP
10% owner
SaleAlert
- Shares
- 160,100
- Price
- $8.00
- Value
- $1,280,432
Raykov Rosty
Director
Sale 10b5-1
- Shares
- 10,000
- Price
- $8.10
- Value
- $81,000
Southpoint Capital Advisors LP
10% owner
SaleAlert
- Shares
- 20,609
- Price
- $9.35
- Value
- $192,614
Southpoint Capital Advisors LP
10% owner
SaleAlert
- Shares
- 19,605
- Price
- $9.47
- Value
- $185,722
Southpoint Capital Advisors LP
10% owner
SaleAlert
- Shares
- 26,900
- Price
- $9.59
- Value
- $257,893
Raykov Rosty
Director
Sale 10b5-1
- Shares
- 10,000
- Price
- $9.78
- Value
- $97,800
Raykov Rosty
Director
Sale 10b5-1
- Shares
- 10,000
- Price
- $8.92
- Value
- $89,200
Raykov Rosty
Director
Sale 10b5-1
- Shares
- 10,000
- Price
- $8.09
- Value
- $80,900
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Brughera Marco Maria Director | Sale | 15,545 | $10.29 | $159,958 | |
| Sep 01, 2026 | Raykov Rosty Former Director | Sale | 10,000 | $12.11 | $121,100 | |
| Aug 31, 2026 | Sayad Pierre Sargis Chief Medical Officer | Sale | 12,000 | $12.18 | $146,160 | |
| Aug 03, 2026 | Raykov Rosty Former Director | Sale | 10,000 | $9.58 | $95,800 | |
| Dec 24, 2025 | Southpoint Capital Advisors LP 10% owner | Sale | 1,000,000 | $7.50 | $7,500,000 | |
| Dec 05, 2025 | Raykov Rosty Director | Sale | 10,000 | $7.54 | $75,400 | |
| Nov 18, 2025 | Southpoint Capital Advisors LP 10% owner | Sale | 19,341 | $8.79 | $170,048 | |
| Nov 17, 2025 | Southpoint Capital Advisors LP 10% owner | Sale | 85,918 | $8.79 | $755,193 | |
| Nov 14, 2025 | Southpoint Capital Advisors LP 10% owner | Sale | 160,100 | $8.00 | $1,280,432 | |
| Nov 05, 2025 | Raykov Rosty Director | Sale | 10,000 | $8.10 | $81,000 | |
| Oct 09, 2025 | Southpoint Capital Advisors LP 10% owner | Sale | 20,609 | $9.35 | $192,614 | |
| Oct 08, 2025 | Southpoint Capital Advisors LP 10% owner | Sale | 19,605 | $9.47 | $185,722 | |
| Oct 07, 2025 | Southpoint Capital Advisors LP 10% owner | Sale | 26,900 | $9.59 | $257,893 | |
| Oct 06, 2025 | Raykov Rosty Director | Sale | 10,000 | $9.78 | $97,800 | |
| Sep 04, 2025 | Raykov Rosty Director | Sale | 10,000 | $8.92 | $89,200 | |
| Aug 05, 2025 | Raykov Rosty Director | Sale | 10,000 | $8.09 | $80,900 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.